These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4549263)

  • 1. [Generalized scleroderma associated at with active chronic hepatitis. Successive apparition of different serum antibodies].
    Husson JM; Petite JP; Homberg JC; Lunel J; Audebert A; Camilleri JP
    Nouv Presse Med; 1974 Dec; 3(45):2717-21. PubMed ID: 4549263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active chronic hepatitis].
    Cachin M; Launois JP
    Nouv Presse Med; 1972 Jul; 1(27):1821-2. PubMed ID: 4537764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic active (aggressive) hepatitis. Differential diagnosis of lupoid (ANA-positive) and cholestatic (AMA-positive) hepatitis].
    Berg PA
    Dtsch Med Wochenschr; 1976 Oct; 101(42):1536-43. PubMed ID: 789040
    [No Abstract]   [Full Text] [Related]  

  • 4. [Active chronic hepatitis with incomplete CREST syndrome: value of anticentromere antibodies].
    Devars du Mayne JF; Yeni P; Harlé X; Chagnon JP; Boulanger F; Brion N
    Gastroenterol Clin Biol; 1982 Nov; 6(11):949. PubMed ID: 6983991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Active chronic hepatitis. Criteria adopted and results in recent specialist studies].
    Carotti A
    Minerva Med; 1980 Nov; 71(47):3429-34. PubMed ID: 7454095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of anti-Scl-70 antibody and its clinical significance in progressive systemic sclerosis].
    Jiang M
    Zhonghua Yi Xue Za Zhi; 1986 Jun; 66(6):346-8, 384. PubMed ID: 3094898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis].
    Storch W; Emmrich R; Petzold H
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of active chronic hepatitis with antimicrosomal and antinuclear antibodies].
    Marchesini G; Masi M; Paolucci P; Franceschi C; Perocco P; Zauli D
    Minerva Pediatr; 1977 Apr; 29(12):827-32. PubMed ID: 301599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data].
    Pirotte J; Rauber G; Ruyters L
    Arch Fr Mal App Dig; 1972; 61(1):7-18. PubMed ID: 4115477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Antismooth muscle antibody in scleroderma.
    Kitridou RC; Fleischmajer R; Lagosky PA
    Arthritis Rheum; 1975; 18(5):526. PubMed ID: 1081396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liver and generalized scleroderma].
    Buffet C; Husson JM
    Nouv Presse Med; 1974 Dec; 3(45):2701-2. PubMed ID: 4459862
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].
    Jiang M; Wang HZ; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoimmune chronic active hepatitis].
    Malinowska J
    Przegl Epidemiol; 1994; 48(3):225-34. PubMed ID: 7938626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic active liver disease reexamined: prognosis hopeful.
    Summerskill WH
    Gastroenterology; 1974 Mar; 66(3):450-64. PubMed ID: 4591728
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification and prognosis of chronic hepatitis].
    Erlinger S; Degott C
    Gastroenterol Clin Biol; 1979; 3(8-9):673-82. PubMed ID: 389728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunopathogenesis of chronic inflammatory liver diseases].
    Meyer zum Büschenfelde
    Ergeb Inn Med Kinderheilkd; 1972; 32():31-81. PubMed ID: 4556562
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic active hepatitis: a plea for conservative management.
    Knodell RG; Farleigh RM
    Geriatrics; 1981 Apr; 36(4):111-5. PubMed ID: 7203015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.